Cc1ccc2oc3c(c(=O)c2c1)C(c1ccc(OCC(N)=O)cc1)N(Cc1ccc2c(c1)OCO2)C3=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?